Progression free survival (PFS) extended to 9.1 months in ADC resistant patient - quadruple the PFS of patients in similar studies 1, 2, 3Significant reduction of “Eye-Bulging” metastatic breast...
BriaCell doubles Progression-Free-Survival (PFS) and Clinical Benefit Rate vs historical results in the literatureBria-IMT™ PFS compares favorably to PFS of most recent treatment in 48% of...
PHILADELPHIA and VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
Study to evaluate the effects of Bria-OTS™ in combination with anti-PD-1 antibody tislelizumab, in advanced, late stage, heavily pretreated metastatic breast cancer. PHILADELPHIA and VANCOUVER...
83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression free survival (PFS) of 4.1 months in ADC...
PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
PHILADELPHIA and VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MDTwo poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.32 | -25.6 | 1.25 | 1.33 | 0.86 | 33337 | 1.07004038 | CS |
4 | -0.77 | -45.2941176471 | 1.7 | 1.7 | 0.86 | 14634 | 1.20768114 | CS |
12 | -2.02 | -68.4745762712 | 2.95 | 3.27 | 0.86 | 10826 | 1.66549822 | CS |
26 | -4.62 | -83.2432432432 | 5.55 | 5.81 | 0.86 | 9670 | 2.7691701 | CS |
52 | -7.35 | -88.768115942 | 8.28 | 10.29 | 0.86 | 6878 | 4.11898322 | CS |
156 | -9.91 | -91.4206642066 | 10.84 | 15.05 | 0.86 | 7682 | 7.35857513 | CS |
260 | -9.91 | -91.4206642066 | 10.84 | 15.05 | 0.86 | 7682 | 7.35857513 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.